Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop
- PMID: 1590237
- DOI: 10.1016/0002-9149(92)90901-a
Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop
Abstract
Idiopathic dilated cardiomyopathy (IDC) is the primary indication for cardiac transplantation, with associated costs of approximately $177 million per year. Recognizing the economic implications of IDC, the increasing incidence, and the limited information on pathogenesis and prognosis, the National Heart, Lung, and Blood Institute convened a workshop on the Prevalence and Etiology of Idiopathic Dilated Cardiomyopathy on June 13 to 14, 1991. The difficulties of studying the disease were reviewed, including its relatively low prevalence, its potentially pluricausal nature, and the fact that it is often a diagnosis of exclusion. Still, it presents significant challenges to the cardiovascular scientific community, since the mechanism of myocardial damage and related etiologic and prognostic factors are virtually unknown. The development of more reliable measures of immune-mediated damage and noninvasive measures of impaired cardiac function present new research opportunities in this disorder. Standardized diagnostic criteria for use in observational and interventional trials were developed, and priorities for future research were proposed. Population-based registries and nested case-control studies, where feasible, are appropriate study designs for tracking incidence and prevalence, and for identifying risk factors, respectively. Interventional studies should focus on secondary prevention, through modifying immune-mediated damage in clinically evident dilated cardiomyopathy, and through prevention of sudden death in patients with the disorder. Primary prevention trials must await the identification of modifiable risk factors and of appropriate and effective interventions.
Comment in
-
Noninvasive diagnosis of idiopathic dilated cardiomyopathy.Am J Cardiol. 1993 Feb 15;71(5):494. doi: 10.1016/0002-9149(93)90475-r. Am J Cardiol. 1993. PMID: 8498993 No abstract available.
Similar articles
-
Differences in Presentation and Outcomes Between Children With Familial Dilated Cardiomyopathy and Children With Idiopathic Dilated Cardiomyopathy: A Report From the Pediatric Cardiomyopathy Registry Study Group.Circ Heart Fail. 2017 Feb;10(2):e002637. doi: 10.1161/CIRCHEARTFAILURE.115.002637. Circ Heart Fail. 2017. PMID: 28193717 Free PMC article.
-
Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.Circ Heart Fail. 2013 Sep 1;6(5):913-21. doi: 10.1161/CIRCHEARTFAILURE.112.000120. Epub 2013 Jul 25. Circ Heart Fail. 2013. PMID: 23888044
-
Characterization and Long-Term Prognosis of Postmyocarditic Dilated Cardiomyopathy Compared With Idiopathic Dilated Cardiomyopathy.Am J Cardiol. 2016 Sep 15;118(6):895-900. doi: 10.1016/j.amjcard.2016.05.063. Epub 2016 Jun 28. Am J Cardiol. 2016. PMID: 27453513
-
The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years.Heart Fail Clin. 2010 Oct;6(4):401-13, vii. doi: 10.1016/j.hfc.2010.05.002. Heart Fail Clin. 2010. PMID: 20869642 Free PMC article. Review.
-
Sudden cardiac death in non-ischemic dilated cardiomyopathy: a critical appraisal of existing and potential risk stratification tools.Int J Cardiol. 2013 Jul 31;167(2):335-41. doi: 10.1016/j.ijcard.2012.07.014. Epub 2012 Aug 11. Int J Cardiol. 2013. PMID: 22889703 Review.
Cited by
-
Preliminary investigation of multiparametric strain Z-score (MPZS) computation using displacement encoding with simulated echoes (DENSE) and radial point interpretation method (RPIM).J Magn Reson Imaging. 2016 Oct;44(4):993-1002. doi: 10.1002/jmri.25239. Epub 2016 Mar 31. J Magn Reson Imaging. 2016. PMID: 27038246 Free PMC article.
-
Diagnosis, prevalence, and screening of familial dilated cardiomyopathy.Expert Opin Orphan Drugs. 2015;3(8):869-876. doi: 10.1517/21678707.2015.1057498. Epub 2015 Jun 22. Expert Opin Orphan Drugs. 2015. PMID: 27547593 Free PMC article.
-
Dilated cardiomyopathy: the complexity of a diverse genetic architecture.Nat Rev Cardiol. 2013 Sep;10(9):531-47. doi: 10.1038/nrcardio.2013.105. Epub 2013 Jul 30. Nat Rev Cardiol. 2013. PMID: 23900355 Review.
-
Nexilin mutations destabilize cardiac Z-disks and lead to dilated cardiomyopathy.Nat Med. 2009 Nov;15(11):1281-8. doi: 10.1038/nm.2037. Epub 2009 Nov 1. Nat Med. 2009. PMID: 19881492
-
Molecular studies in familial dilated cardiomyopathy - A pilot study.Int J Cardiol Heart Vasc. 2022 Apr 11;40:101023. doi: 10.1016/j.ijcha.2022.101023. eCollection 2022 Jun. Int J Cardiol Heart Vasc. 2022. PMID: 35463915 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources